| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0471e47f3a2760e9befddc375477afa7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2021-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b13a9ec20c537b34bce7b44ad4d1ac9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f19ebaf7ff8fa8edc8698e37d22d2649
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b61e43ebd824af7b5126905b14814c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c1242643930e5fcc654e8c50114e9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74b204ec0d622cef057f3ca2effd3c39 |
| publicationDate |
2022-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022112392-A1 |
| titleOfInvention |
Anti-sars-cov-2 antibody molecules |
| abstract |
Anti-SARS-CoV-2 antibody molecules or binding fragments thereof are disclosed. These anti-SARS-CoV-2 antibody molecules or binding fragments can be used in the treatment or prevention of SARS-CoV-2 infection and/or SARS-CoV-2 associated disorder. |
| priorityDate |
2020-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |